Calcium Carbonate Core-Shell Particles for Incorporation of 225Ac and Their Application in Local α-Radionuclide Therapy

Manylion Llyfryddiaeth
Parent link:ACS Applied Materials and Interfaces
Vol. 13, iss. 22.— 2021.— [P. 25599–25610]
Awdur Corfforaethol: Национальный исследовательский Томский политехнический университет Исследовательская школа химических и биомедицинских технологий
Awduron Eraill: Muslimov A. R. Albert, Antuganov D. O. Dmitrii, Tarakanchikova Ya. V. Yana, Zhukov M. V. Mikhail, Nadporojskii M. A. Michail, Zyuzin M. V. Mikhail, Timin A. S. Aleksandr Sergeevich
Crynodeb:Title screen
Actinium-225 (225Ac) radiolabeled submicrometric core-shell particles (SPs) made of calcium carbonate (CaCO3) coated with biocompatible polymers [tannic acid-human serum albumin (TA/HSA)] have been developed to improve the efficiency of local α-radionuclide therapy in melanoma models (B16-F10 tumor-bearing mice). The developed 225Ac-SPs possess radiochemical stability and demonstrate effective retention of 225Ac and its daughter isotopes. The SPs have been additionally labeled with zirconium-89 (89Zr) to perform the biodistribution studies using positron emission tomography-computerized tomography (PET/CT) imaging for 14 days after intratumoral injection. According to the PET/CT analysis, a significant accumulation of 89Zr-SPs in the tumor area is revealed for the whole investigation period, which correlates with the direct radiometry analysis after intratumoral administration of 225Ac-SPs. The histological analysis has revealed no abnormal changes in healthy tissue organs after treatment with 225Ac-SPs (e.g., no acute pathologic findings are detected in the liver and kidneys). At the same time, the inhibition of tumor growth has been observed as compared with control samples [nonradiolabeled SPs and phosphate-buffered saline (PBS)]. The treatment of mice with 225Ac-SPs has resulted in prolonged survival compared to the control samples. Thus, our study validates the application of 225Ac-doped core-shell submicron CaCO3 particles for local α-radionuclide therapy.
Режим доступа: по договору с организацией-держателем ресурса
Cyhoeddwyd: 2021
Pynciau:
Mynediad Ar-lein:https://doi.org/10.1021/acsami.1c02155
Fformat: Electronig Pennod Llyfr
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=667956